Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 1
1983 3
1984 1
1985 2
1986 1
1987 7
1988 3
1989 4
1990 6
1991 6
1992 11
1993 15
1994 10
1995 9
1996 14
1997 21
1998 12
1999 22
2000 14
2001 31
2002 44
2003 50
2004 72
2005 85
2006 113
2007 125
2008 120
2009 160
2010 230
2011 271
2012 285
2013 413
2014 479
2015 510
2016 538
2017 592
2018 622
2019 669
2020 816
2021 982
2022 554
Text availability
Article attribute
Article type
Publication date

Search Results

7,071 results
Results by year
Filters applied: . Clear all
Page 1
Authors' response.
Jiang T, Tang GH. Jiang T, et al. Am J Orthod Dentofacial Orthop. 2021 Nov;160(5):642-643. doi: 10.1016/j.ajodo.2021.08.004. Am J Orthod Dentofacial Orthop. 2021. PMID: 34752249 No abstract available.
Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer.
Shi AP, Tang XY, Xiong YL, Zheng KF, Liu YJ, Shi XG, Lv Y, Jiang T, Ma N, Zhao JB. Shi AP, et al. Among authors: jiang t. Front Immunol. 2022 Jan 17;12:785091. doi: 10.3389/fimmu.2021.785091. eCollection 2021. Front Immunol. 2022. PMID: 35111155 Free PMC article. Review.
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial.
Ren S, Chen J, Xu X, Jiang T, Cheng Y, Chen G, Pan Y, Fang Y, Wang Q, Huang Y, Yao W, Wang R, Li X, Zhang W, Zhang Y, Hu S, Guo R, Shi J, Wang Z, Cao P, Wang D, Fang J, Luo H, Geng Y, Xing C, Lv D, Zhang Y, Yu J, Cang S, Yang Z, Shi W, Zou J, Zhou C; CameL-sq Study Group. Ren S, et al. Among authors: jiang t. J Thorac Oncol. 2022 Apr;17(4):544-557. doi: 10.1016/j.jtho.2021.11.018. Epub 2021 Dec 16. J Thorac Oncol. 2022. PMID: 34923163 Clinical Trial.
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments.
Pang K, Jiang R, Zhang W, Yang Z, Li LL, Shimozawa M, Tambaro S, Mayer J, Zhang B, Li M, Wang J, Liu H, Yang A, Chen X, Liu J, Winblad B, Han H, Jiang T, Wang W, Nilsson P, Guo W, Lu B. Pang K, et al. Among authors: jiang t. Cell Res. 2022 Feb;32(2):157-175. doi: 10.1038/s41422-021-00582-x. Epub 2021 Nov 17. Cell Res. 2022. PMID: 34789895 Free PMC article.
Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy.
Long H, Jia Q, Wang L, Fang W, Wang Z, Jiang T, Zhou F, Jin Z, Huang J, Zhou L, Hu C, Wang X, Zhang J, Ba Y, Gong Y, Zeng X, Zeng D, Su X, Alexander PB, Wang L, Wang L, Wan YY, Wang XF, Zhang L, Li QJ, Zhu B. Long H, et al. Among authors: jiang t. Cancer Cell. 2022 Jun 13;40(6):674-693.e7. doi: 10.1016/j.ccell.2022.04.018. Epub 2022 May 19. Cancer Cell. 2022. PMID: 35594863
Recent Advances of Upconversion Nanomaterials in the Biological Field.
Gao C, Zheng P, Liu Q, Han S, Li D, Luo S, Temple H, Xing C, Wang J, Wei Y, Jiang T, Chen W. Gao C, et al. Among authors: jiang t. Nanomaterials (Basel). 2021 Sep 22;11(10):2474. doi: 10.3390/nano11102474. Nanomaterials (Basel). 2021. PMID: 34684916 Free PMC article. Review.
7,071 results